Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2470)
All Articles published online
|
Jul 21, 2007 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bal N, Yildirim S, Nursal TZ, Bolat F, Kayaselçuk F. Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type. World J Gastroenterol 2007; 13(27): 3726-3729 [PMID: 17659733 DOI: 10.3748/wjg.v13.i27.3726] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i27/3726.htm |
| Number | Citing Articles |
| 1 |
Yun Kyung Kang, Seong Woo Hong, Hyucksang Lee, Woo Ho Kim. Prognostic implications of ezrin expression in human hepatocellular carcinoma. Molecular Carcinogenesis 2010; 49(9): 798 doi: 10.1002/mc.20653
|
| 2 |
Barbara Chifenti, Mariangela Morelli, Michele Zavaglia, Domenico A. Coviello, Silvana Guerneri, Annalisa Santucci, Alessandro Paffetti, Massimo Masetti, Maria Teresa Locci, Gloria Bertacca, Alessandra Capodanno, Paola Collecchi, Daniela Campani, Franco Mosca, Generoso Bevilacqua, Andrea O. Cavazzana. Establishment and Characterization of 4 New Human Pancreatic Cancer Cell Lines. Pancreas 2009; 38(2): 184 doi: 10.1097/MPA.0b013e31818c746a
|
| 3 |
Daiki Okamura, Masayuki Ohtsuka, Fumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, Atsushi Kato, Masaru Miyazaki. Ezrin expression is associated with hepatocellular carcinoma possibly derived from progenitor cells and early recurrence after surgical resection. Modern Pathology 2008; 21(7): 847 doi: 10.1038/modpathol.2008.59
|
| 4 |
Walid S.H. Elsayed, Ola A. Harb, Nashwa Nawar, Heba F. Taha, Ahmed M. Abdou. Combined Ezrin overexpression and E-cadherin downregulation as predictors of invasiveness, higher incidence of metastases, progression and poor prognosis in patients with cervical cancer. Egyptian Journal of Pathology 2018; 38(1): 35 doi: 10.1097/01.XEJ.0000534715.52780.a4
|
| 5 |
Kotoku Kawaguchi, Shinji Asano. Pathophysiological Roles of Actin-Binding Scaffold Protein, Ezrin. International Journal of Molecular Sciences 2022; 23(6): 3246 doi: 10.3390/ijms23063246
|
| 6 |
Marcelo Patara, Erika Maria Monteiro Santos, Renata de Almeida Coudry, Fernando Augusto Soares, Fábio Oliveira Ferreira, Benedito Mauro Rossi. Ezrin Expression as a Prognostic Marker in Colorectal Adenocarcinoma. Pathology & Oncology Research 2011; 17(4): 827 doi: 10.1007/s12253-011-9389-4
|
| 7 |
Jingchun Jin, Tiefeng Jin, Meiling Quan, Yingshi Piao, Zhenhua Lin. Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma. Diagnostic Pathology 2012; 7(1) doi: 10.1186/1746-1596-7-135
|
| 8 |
Yazhou Cui, Tianliang Li, Denglu Zhang, Jinxiang Han. Expression of Ezrin and Phosphorylated Ezrin (pEzrin) in Pancreatic Ductal Adenocarcinoma. Cancer Investigation 2010; 28(3): 242 doi: 10.3109/07357900903124498
|
| 9 |
Zhe Wang, Mao-Lin He, Jin-Min Zhao, Hai-Hui Qing, Yang Wu. Meta-analysis of Associations of the Ezrin Gene with Human Osteosarcoma Response to Chemotherapy and Prognosis. Asian Pacific Journal of Cancer Prevention 2013; 14(5): 2753 doi: 10.7314/APJCP.2013.14.5.2753
|
| 10 |
Li Li, Yuan-Yu Wang, Zhong-Sheng Zhao, Jie Ma. Ezrin is Associated with Gastric Cancer Progression and Prognosis. Pathology & Oncology Research 2011; 17(4): 909 doi: 10.1007/s12253-011-9402-y
|
| 11 |
Expression of Ezrin in Human Embryonic, Fetal, and Normal Adult Tissues. Journal of Histochemistry & Cytochemistry 2011; 59(11): 1001 doi: 10.1369/0022155411418661
|
| 12 |
Feng Liang, Yangxin Wang, Ligen Shi, Jianmin Zhang. Association of Ezrin expression with the progression and prognosis of gastrointestinal cancer: a meta-analysis. Oncotarget 2017; 8(54): 93186 doi: 10.18632/oncotarget.21473
|
| 13 |
Afrodite Athanasopoulou, Panagiotis Aroukatos, Dimitrios Nakas, Maria Repanti, Helen Papadaki, Vasiliki Bravou. Decreased ezrin and paxillin expression in human urothelial bladder tumors correlate with tumor progression. Urologic Oncology: Seminars and Original Investigations 2013; 31(6): 836 doi: 10.1016/j.urolonc.2011.07.003
|
| 14 |
Xiao-Qin Zhang, Guo-Ping Chen, Tao Wu, Jian-Ping Yan, Jian-Ying Zhou. Expression and Clinical Significance of Ezrin in Non–Small-Cell Lung Cancer. Clinical Lung Cancer 2012; 13(3): 196 doi: 10.1016/j.cllc.2011.04.002
|
| 15 |
Bulent Cetin, Ipek Isık Gonul, Suleyman Buyukberber, Barıs Afsar, Ozge Gumusay, Efnan Algın, Nedim Turan, Ahmet Ozet, Mustafa Benekli, Ugur Coskun. The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors. Tumor Biology 2015; 36(11): 8471 doi: 10.1007/s13277-015-3589-6
|
| 16 |
TARO TOBO, MINAKO HIRAHASHI, TAKASHI YAO, SHINICHI AISHIMA, YOSHINAO ODA. Ezrin expression and its phosphorylation in gastric carcinoma with lymphoid stroma and Epstein-Barr virus infection. Molecular and Clinical Oncology 2013; 1(2): 220 doi: 10.3892/mco.2012.56
|
| 17 |
Jean Carlos Lipreri da Silva, Hugo Passos Vicari, João Agostinho Machado-Neto. Perspectives for Targeting Ezrin in Cancer Development and Progression. Future Pharmacology 2023; 3(1): 61 doi: 10.3390/futurepharmacol3010005
|